These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 233682)

  • 1. Pathophysiological studies in idiopathic hypercalciuria: use of an oral calcium tolerance test to characterize distinctive hypercalciuric subgroups.
    Broadus AE; Dominguez M; Bartter FC
    J Clin Endocrinol Metab; 1978 Oct; 47(4):751-60. PubMed ID: 233682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hypercalciurias. Causes, parathyroid functions, and diagnostic criteria.
    Pak CY; Oata M; Lawrence EC; Snyder W
    J Clin Invest; 1974 Aug; 54(2):387-400. PubMed ID: 4367891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of calcium intake and the status of intestinal calcium absorption on the diagnostic utility of measurements of 24-hour cyclic adenosine 3',5'-monophosphate excretion.
    Broadus AE; Lang R; Kliger AS
    J Clin Endocrinol Metab; 1981 Jun; 52(6):1085-9. PubMed ID: 6262362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathogenesis of idiopathic hypercalciuria: evidence for parathyroid hyperfunction.
    Evans RA; Hills E; Wong SY; Wyndham LE; Eade Y; Dunstan CR
    Q J Med; 1984; 53(209):41-53. PubMed ID: 6324269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exaggerated natriuretic and calciuric responses to hydrochlorothiazide in renal hypercalciuria but not in absorptive hypercalciuria.
    Sakhaee K; Nicar MJ; Brater DC; Pak CY
    J Clin Endocrinol Metab; 1985 Nov; 61(5):825-9. PubMed ID: 4044775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An experimental human model of 1,25-dihydroxyvitamin D-mediated hypercalciuria.
    Broadus AE; Erickson SB; Gertner JM; Cooper K; Dobbins JW
    J Clin Endocrinol Metab; 1984 Aug; 59(2):202-6. PubMed ID: 6330152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the intravenous administration of calcium on nephrogenous cyclic AMP: use as a parathyroid suppression test.
    Broadus AE; Deftos LJ; Bartter FC
    J Clin Endocrinol Metab; 1978 Mar; 46(3):477-87. PubMed ID: 221521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The usefulness of an oral calcium tolerance test in the choice of management of patients with idiopathic hypercalciuria.
    Naafs MA; Essed E; Hirdes WH; Hackeng WH; Fischer HR
    Neth J Med; 1990 Jun; 36(5-6):223-7. PubMed ID: 2168524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of secondary hyperparathyroidism in most patients with renal hypercalciuria.
    Olmer M; Berland Y; Argemi B
    Kidney Int Suppl; 1983 Dec; 16():S175-9. PubMed ID: 6330424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology and therapy of hypercalciuria in patients who form recurrent stones.
    Ritz E; Schmidt-Gayk H; Möhring K
    Eur Urol; 1975; 1(3):131-3. PubMed ID: 183957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possibility of elevated parathyroid function in patients with calcium-containing nephrolithiasis as compared with normal controls.
    Kitamura T; Hirano Y; Ueda D; Niijima T
    Eur Urol; 1987; 13(1-2):90-9. PubMed ID: 3034619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case report: primary hyperparathyroidism--comparison before and after parathyroidectomy by oral calcium tolerance test].
    Sakamoto W; Kawashima H; Nishijima T; Senju M; Kishimoto T; Maekawa M
    Hinyokika Kiyo; 1987 Dec; 33(12):2084-9. PubMed ID: 2834926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of adenosine 3',5'-monophosphate excretion and an oral calcium tolerance test in the diagnosis of mild primary hyperparathyroidism.
    Madvig P; Young G; Marcus R
    J Clin Endocrinol Metab; 1984 Mar; 58(3):480-7. PubMed ID: 6319454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A detailed evaluation of oral phosphate therapy in selected patients with primary hyperparathyroidism.
    Broadus AE; Magee JS; Mallette LE; Horst RL; Lang R; Jensen PS; Gertner JM; Baron R
    J Clin Endocrinol Metab; 1983 May; 56(5):953-61. PubMed ID: 6300178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis of hypercalciuria in calcium nephrolithiasis (author's transl)].
    Joost J; Puschendorf B
    Dtsch Med Wochenschr; 1980 Jul; 105(28):988-92. PubMed ID: 6250784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A consideration of the hormonal basis and phosphate leak hypothesis of absorptive hypercalciuria.
    Broadus AE; Insogna KL; Lang R; Mallette LE; Oren DA; Gertner JM; Kliger AS; Ellison AF
    J Clin Endocrinol Metab; 1984 Jan; 58(1):161-9. PubMed ID: 6546292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of normocalcemic hyperparathyroidism in idiopathic hypercalciuria: evaluation by dietary calcium deprivation test.
    Mazzuoli GF; D'Erasmo E; Minisola S; Mancini D; Malaguti Aliberti L; Scarda A; Bracci U; Miano L
    Eur Urol; 1981; 7(6):331-4. PubMed ID: 6269860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-related changes in parathyroid hormone and parathyroid hormone action in normal humans.
    Marcus R; Madvig P; Young G
    J Clin Endocrinol Metab; 1984 Feb; 58(2):223-30. PubMed ID: 6319444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of dietary calcium on serum 1,25-dihydroxyvitamin D concentrations in renal stone formers.
    D'Amour P; Gascon-Barré M; Dufresne L; Perreault JP
    Clin Endocrinol (Oxf); 1984 Nov; 21(5):549-62. PubMed ID: 6094046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating parathyroid hormone activity: familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism.
    Marx SJ; Spiegel AM; Brown EM; Windeck R; Gardner DG; Downs RW; Attie M; Aurbach GD
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1190-7. PubMed ID: 233692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.